{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:17:40Z","timestamp":1789957060437,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent publications suggest PCV2 vaccine-induced protection is superior when the vaccine and challenge are closely matched. PCV2\u2019s evolutionary rate, propensity for recombination, and genotype shifting, all provide rationale for modernizing PCV2 vaccines. One mechanism to increase a vaccine\u2019s epitope breadth is by designing a bivalent vaccine. The objective of these studies was to evaluate efficacy of a monovalent (PCV1-2 chimera, cPCV2a or cPCV2b) and bivalent (cPCV2a\u2013cPCV2b) vaccine in terms of homologous and heterologous efficacy. In Study A, pigs were vaccinated with cPCV2a or saline and challenged with PCV2a or PCV2b. In Study B, pigs were vaccinated with cPCV2a, cPCV2a\u2013cPCV2b bivalent, or saline, and challenged with PCV2a. In Study C, pigs were vaccinated with cPCV2b, cPCV2a\u2013cPCV2b bivalent, or saline, and challenged with PCV2b. In all studies vaccines and saline were administered intramuscularly to pigs at three to four weeks of age. Virulent PCV2b or PCV2a was administered to all animals approximately three weeks post-vaccination. Both mono and bivalent vaccinated groups demonstrated significantly lower viremia, percent of animals ever viremic, percent of animals with lymphoid depletion and\/or histiocytic replacement, and percent of animals with PCV2 colonization of lymphoid tissues compared to saline controls. In Study A, a biologically relevant, though not significantly different, improvement in homologous versus heterologous protection was observed. In Studies B and C, biologically superior efficacy of the bivalent cPCV2a\u2013cPCV2b vaccine compared to either monovalent vaccine was demonstrated. Taken together, cross-protection among mismatched PCV2 vaccine and challenge genotypes is not 100%; a bivalent PCV2 vaccine may provide the best opportunity to broaden coverage to circulating strains of PCV2.<\/jats:p>","DOI":"10.1186\/s13567-022-01029-w","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:23:44Z","timestamp":1645230224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines"],"prefix":"10.1186","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2349-0818","authenticated-orcid":false,"given":"Meggan","family":"Bandrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Balasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeri","family":"Toepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"1029_CR1","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/JVI.01719-09","volume":"83","author":"C Firth","year":"2009","unstructured":"Firth C, Charleston MA, Duffy S, Shapiro B, Homes EC (2009) Insights into the evolutionary history of an emerging livestock pathogen: porcine circovirus 2. J Virol 83:12813\u201312821","journal-title":"J Virol"},{"key":"1029_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.virusres.2011.10.007","volume":"164","author":"J Segal\u00e9s","year":"2012","unstructured":"Segal\u00e9s J (2012) Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res 164:10\u201319","journal-title":"Virus Res"},{"key":"1029_CR3","doi-asserted-by":"publisher","first-page":"e0208585","DOI":"10.1371\/journal.pone.0208585","volume":"13","author":"G Franzo","year":"2018","unstructured":"Franzo G, Segal\u00e9s J (2018) Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology. PLoS One 13:e0208585","journal-title":"PLoS ONE"},{"key":"1029_CR4","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.rvsc.2013.06.004","volume":"95","author":"PF Gerber","year":"2013","unstructured":"Gerber PF, Johnson J, Shen H, Striegel D, Xiao C-T, Halbur PG, Opriessnig T (2013) Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs. Res Vet Sci 95:775\u2013781","journal-title":"Res Vet Sci"},{"key":"1029_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ympev.2016.04.028","volume":"100","author":"G Franzo","year":"2016","unstructured":"Franzo G, Cortey M, Segal\u00e9s J, Hughes J, Drigo M (2016) Phylodynamic analysis of porcine circovirus type 2 reveals global waves of emerging genotypes and the circulation of recombinant forms. Mol Phylogenet Evol 100:269\u2013280","journal-title":"Mol Phylogenet Evol"},{"key":"1029_CR6","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pathogens9070533","volume":"9","author":"V Saporiti","year":"2020","unstructured":"Saporiti V, Martorell S, Cruz TT, Klaumann F, Correa-Fiz F, Balasch M, Sibila M, Segales J (2020) Frequency of detection and phylogenetic analysis of porcine circovirus 3 (PCV-3) in healthy primiparous and multiparous sows and their mummified fetuses and stillborn. Pathogens 9:533\u2013544","journal-title":"Pathogens"},{"key":"1029_CR7","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1099\/vir.0.000100","volume":"96","author":"CT Xiao","year":"2015","unstructured":"Xiao CT, Halbur PG, Opriessnig T (2015) Global molecular genetic analysis of porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d. J Gen Virol 96:1830\u20131841","journal-title":"J Gen Virol"},{"key":"1029_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.vetmic.2016.11.009","volume":"197","author":"C-T Xiao","year":"2016","unstructured":"Xiao C-T, Harmon KM, Halbur PG, Opriessnig T (2016) PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014\u20132016. Vet Microbiol 197:72\u201377","journal-title":"Vet Microbiol"},{"key":"1029_CR9","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1111\/tbed.12768","volume":"65","author":"S Yang","year":"2017","unstructured":"Yang S, Yin S, Shang Y, Liu B, Yuan L, Zafar Khan MU, Liu X, Cai J (2017) Phylogenetic and genetic variation analyses of porcine circovirus type 2 isolated from China. Transbound Emerg Dis 65:e383\u2013e392","journal-title":"Transbound Emerg Dis"},{"key":"1029_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.vetmic.2012.12.019","volume":"163","author":"T Opriessnig","year":"2013","unstructured":"Opriessnig T, Xiao C-T, Gerber PF, Halbur PG (2013) Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2. Vet Microbiol 163:177\u2013183","journal-title":"Vet Microbiol"},{"key":"1029_CR11","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1099\/vir.0.042085-0","volume":"93","author":"D Saha","year":"2012","unstructured":"Saha D, Lefebvre DJ, Huang L, Delputte PL, Van Doorsselaere J, Nauwynck HJ (2012) Single amino acid mutations in the capsid switch the neutralization phenotype of porcine circovirus 2. J Gen Virol 93:1548\u20131555","journal-title":"J Gen Virol"},{"key":"1029_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bjm.2017.08.007","volume":"49","author":"D Gava","year":"2018","unstructured":"Gava D, Serrao VHB, Fernandes LT, Cantao ME, Ciacci-Zanella JR, Mores N, Schaefer R (2018) Structure analysis of capsid protein of Porcine circovirus type 2 from pigs with systemic disease. Braz J Microbiol 49:351\u2013357","journal-title":"Braz J Microbiol"},{"key":"1029_CR13","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1128\/JVI.78.15.8135-8145.2004","volume":"78","author":"P Lekcharoensuk","year":"2004","unstructured":"Lekcharoensuk P, Morozov I, Paul PS, Thangthumniyom N, Wajjawalku W, Meng XJ (2004) Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol 78:8135\u20138145","journal-title":"J Virol"},{"key":"1029_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.virusres.2011.10.027","volume":"164","author":"S Krakowka","year":"2012","unstructured":"Krakowka S, Allan G, Ellis J, Hamberg A, Charreyre C, Kaufmann E, Brooks C, Meehan B (2012) A nine-base nucleotide sequence in the porcine circovirus type 2 (PCV2) nucleocapsid gene determines viral replication and virulence. Virus Res 164:90\u201399","journal-title":"Virus Res"},{"key":"1029_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vetmic.2011.11.030","volume":"157","author":"D Saha","year":"2012","unstructured":"Saha D, Huang L, Bussalleu E, Lefebvre DJ, Fort M, Van Doorsselaere J, Nauwynck HJ (2012) Antigenic subtyping and epitopes\u2019 competition analysis of porcine circovirus type 2 using monoclonal antibodies. Vet Microbiol 157:13\u201322","journal-title":"Vet Microbiol"},{"key":"1029_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1297-9716-45-29","volume":"45","author":"S Kurtz","year":"2014","unstructured":"Kurtz S, Grau-Roma L, Cortey M, Fort M, Rodr\u00edguez F, Sibila M, Segal\u00e9s J (2014) Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins. Vet Res 45:29","journal-title":"Vet Res"},{"key":"1029_CR17","first-page":"1","volume":"9","author":"M Constans","year":"2015","unstructured":"Constans M, Ssemadaali M, Kolyvushko O, Ramamoorthy S (2015) Antigenic determinants of possible vaccine escape by porcine circovirus subtype 2b Viruses. Bioinform Biol Insights 9:1\u201312","journal-title":"Bioinform Biol Insights"},{"key":"1029_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/v9050099","volume":"9","author":"AK Karuppannan","year":"2017","unstructured":"Karuppannan AK, Opriessnig T (2017) Porcine circovirus type 2 (PCV2) vaccines in the context of current molecular epidemiology. Viruses 9:99","journal-title":"Viruses"},{"key":"1029_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.vaccine.2012.11.030","volume":"31","author":"T Opriessnig","year":"2013","unstructured":"Opriessnig T, O\u2019Neill K, Gerber PF, de Castro AMMG, Gimen\u00e9z-Lirola LG, Beach NM, Zhou L, Meng X-J, Wang C, Halbur PG (2013) A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a\/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Vaccine 31:487\u2013494","journal-title":"Vaccine"},{"key":"1029_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.vetmic.2015.07.026","volume":"180","author":"G Reiner","year":"2015","unstructured":"Reiner G, Hofmeister R, Willems H (2015) Genetic variability of porcine circovirus 2 (PCV2) field isolates from vaccinated and non-vaccinated pig herds in Germany. Vet Microbiol 180:41\u201348","journal-title":"Vet Microbiol"},{"key":"1029_CR21","first-page":"39458","volume":"6","author":"G Franzo","year":"2016","unstructured":"Franzo G, Tucciarone CM, Cecchinato M, Drigo M (2016) Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study. Nature Sci Rep 6:39458","journal-title":"Nature Sci Rep"},{"key":"1029_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.prevetmed.2013.08.004","volume":"116","author":"P Alarcon","year":"2014","unstructured":"Alarcon P, Wieland B, Mateus ALP, Dewberry C (2014) Pig farmers\u2019 perceptions, attitudes, influences and management of information in the decision-making process for disease control. Prev Vet Med 116:223\u2013242","journal-title":"Prev Vet Med"},{"key":"1029_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrg2323","volume":"9","author":"S Duffy","year":"2008","unstructured":"Duffy S, Shackelton LA, Holmes EC (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9:267\u2013276","journal-title":"Nat Rev Genet"},{"key":"1029_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1354\/vp.40-5-521","volume":"40","author":"T Opriessnig","year":"2003","unstructured":"Opriessnig T, Yu S, Gallup JM, Evans RB, Fenaux M, Pallares F, Thacker EL, Brockus CS, Ackerman MR, Thomas P, Meng XJ, Halbur PG (2003) Effect of vaccination with selective bacterins on conventional pigs infected with type 2 porcine circovirus. Vet Pathol 40:521\u2013529","journal-title":"Vet Pathol"},{"key":"1029_CR25","volume-title":"SAS\/STAT User's Guide Version 9.4","author":"SAS Institute Inc","year":"2012","unstructured":"SAS Institute Inc (2012) SAS\/STAT User\u2019s Guide Version 9.4. SAS Institute Inc, Cary"},{"key":"1029_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1051\/vetres\/2010003","volume":"41","author":"T Opriessnig","year":"2010","unstructured":"Opriessnig T, Prickett JR, Madson DM, Shen H-G, Juhan NM, Pogranichniy RM, Meng XJ, Halbur PG (2010) Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs. Vet Res 41:31","journal-title":"Vet Res"},{"key":"1029_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.vaccine.2010.10.050","volume":"29","author":"NM Beach","year":"2011","unstructured":"Beach NM, Ramamoorthy S, Opriessnig T, Wu SQ, Meng X-J (2011) Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the nonpathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtype in pigs. Vaccine 29:221\u2013232","journal-title":"Vaccine"},{"key":"1029_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/104063879901100607","volume":"11","author":"SD Sorden","year":"1999","unstructured":"Sorden SD, Harms PA, Nawagitgul P, Cavanaugh D, Paul PS (1999) Development of a polyclonal-antibody-based immunohistochemical method for the detection of type 2 porcine circovirus in formalin-fixed, paraffin-embedded tissue. J Vet Diagn Invest 11:528\u2013530","journal-title":"J Vet Diagn Invest"},{"key":"1029_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.vetmic.2008.10.007","volume":"135","author":"L Grau-Roma","year":"2009","unstructured":"Grau-Roma L, Hjulsager CK, Sibila M, Kristensen CS, L\u00f3pez-Soria S, En\u00f8e C, Casal J, B\u00f8tner A, Nofrar\u00edas M, Bille-Hansen V, Fraile L, Baekbo P, Segal\u00e9s J, Larsen LE (2009) Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet Microbiol 135:272\u2013282","journal-title":"Vet Microbiol"},{"key":"1029_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.3390\/vaccines9080834","volume":"9","author":"JC Mancera Gracia","year":"2021","unstructured":"Mancera Gracia JC, Smutzer M, Taylor L, Balasch M, Bandrick M (2021) One dose of a novel vaccine containing two genotypes of porcine circovirus (PCV2a and PCV2b) and Mycoplasma hyopneumoniae conferred a duration of immunity of 23 weeks. Vaccines 9:834","journal-title":"Vaccines"},{"key":"1029_CR31","doi-asserted-by":"publisher","first-page":"110034","DOI":"10.1016\/j.vetimm.2020.110034","volume":"223","author":"M Bandrick","year":"2020","unstructured":"Bandrick M, Gutierrez AH, Desai P, Rincon G, Martin WD, Terry FE, De Groot AS, Foss DL (2020) T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines. Vet Immunol Immunopathol 223:110034","journal-title":"Vet Immunol Immunopathol"},{"key":"1029_CR32","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1016\/j.vaccine.2021.08.013","volume":"39","author":"C Venegas-Vargas","year":"2021","unstructured":"Venegas-Vargas C, Taylor LP, Foss DL, Godbee TK, Philip R, Bandrick M (2021) Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a\/PCV2b) and challenge with virulent PCV2d. Vaccine 39:5615\u20135625","journal-title":"Vaccine"},{"key":"1029_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virusres.2011.09.041","volume":"164","author":"NM Beach","year":"2012","unstructured":"Beach NM, Meng XJ (2012) Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 164:33\u201342","journal-title":"Virus Res"},{"key":"1029_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","volume":"1","author":"XJ Meng","year":"2013","unstructured":"Meng XJ (2013) Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci 1:43\u201364","journal-title":"Annu Rev Anim Biosci"},{"key":"1029_CR35","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1099\/vir.0.066423-0","volume":"95","author":"T Opriessnig","year":"2014","unstructured":"Opriessnig T, Xiao C-T, Gerber PF, Halbur PG, Matzinger SR, Meng X-J (2014) Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs. J Gen Virol 95:2495\u20132503","journal-title":"J Gen Virol"},{"key":"1029_CR36","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.1016\/j.vaccine.2014.06.004","volume":"32","author":"T Opriessnig","year":"2014","unstructured":"Opriessnig T, Gerber PF, Xiao C-T, Halbur PG, Matzinger SR, Meng X-J (2014) Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2. Vaccine 32:4342\u20134348","journal-title":"Vaccine"},{"key":"1029_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1586\/14760584.2015.983084","volume":"14","author":"J Segal\u00e9s","year":"2015","unstructured":"Segal\u00e9s J (2015) Best practice and future challenges for vaccination against porcine circovirus type 2. Expert Rev Vaccines 14:473\u2013487","journal-title":"Expert Rev Vaccines"},{"key":"1029_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.rvsc.2015.10.006","volume":"103","author":"MA Ssemadaali","year":"2015","unstructured":"Ssemadaali MA, Ilha M, Ramamoorthy S (2015) Genetic diversity of porcine circovirus type 2 and implications for detection and control. Res Vet Sci 103:179\u2013186","journal-title":"Res Vet Sci"}],"container-title":["Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-022-01029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13567-022-01029-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13567-022-01029-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:29:00Z","timestamp":1645230540000},"score":1,"resource":{"primary":{"URL":"https:\/\/veterinaryresearch.biomedcentral.com\/articles\/10.1186\/s13567-022-01029-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1029"],"URL":"https:\/\/doi.org\/10.1186\/s13567-022-01029-w","relation":{},"ISSN":["1297-9716"],"issn-type":[{"value":"1297-9716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"assertion":[{"value":"28 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Zoetis Institutional Animal Care and Use Committee (Protocol Number: KZ-1655e-2011-11-tkh), and by IACUC of the participating study sites.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Zoetis authors report that they are employees and\/or shareholders of Zoetis and therefore can be considered to have a potential conflict of interest, however, the study was performed in a double blinded, prospective fashion with no foreknowledge of the potential relevance of the results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}